{"disease":{"id":"telangiectasis","name":"telangiectasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05860439","title":"Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias","phase":"","overall_status":"COMPLETED","enrollment_count":191,"lead_sponsor_name":"UPECLIN HC FM Botucatu Unesp","has_results":false},{"nct_id":"NCT03940690","title":"Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT03669393","title":"A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"ThromboGenics","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}